Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11 | 12 | 9 | 139 | 697 |
| Receivables | 6 | 1 | 17 | 5 | 8 |
| Inventories | 0 | 159 | 171 | 5 | N/A |
| TOTAL | $39 | $216 | $240 | $188 | $716 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 4 | 32 | N/A |
| Intangibles | 7 | 8 | 4,008 | 4,549 | 4,631 |
| TOTAL | $7 | $8 | $4,012 | $4,581 | $4,631 |
| Total Assets | $46 | $223 | $4,253 | $4,769 | $5,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 816 | 512 | 178 | 15 | 15 |
| Accounts payable and accrued liabilities | 150 | 249 | 213 | 12 | 116 |
| Accrued Expenses | 20 | 20 | 22 | 32 | 21 |
| Other current liabilities | 244 | 580 | 636 | 663 | 198 |
| TOTAL | $1,229 | $1,361 | $1,054 | $744 | $350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 140 |
| TOTAL | $0 | $0 | $0 | $11 | $140 |
| Total Liabilities | $1,229 | $1,361 | $1,054 | $755 | $490 |
| Shareholders' Equity | |||||
| Common Shares | 9,701 | 9,701 | 9,701 | 9,701 | 9,701 |
| Retained earnings | -12,204 | -12,131 | -7,735 | -6,661 | -5,009 |
| Other shareholders' equity | 1,320 | 1,293 | 1,233 | 975 | 165 |
| TOTAL | $-1,183 | $-1,137 | $3,199 | $4,014 | $4,857 |
| Total Liabilities And Equity | $46 | $223 | $4,253 | $4,769 | $5,347 |